SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-224301
Filing Date
2017-07-07
Accepted
2017-07-07 16:44:32
Documents
4
Period of Report
2017-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d224694d8k.htm 8-K 21499
2 EX-1.1 d224694dex11.htm EX-1.1 8932
3 EX-5.1 d224694dex51.htm EX-5.1 9663
4 GRAPHIC g224694001.jpg GRAPHIC 1436
  Complete submission text file 0001193125-17-224301.txt   43371
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35837 | Film No.: 17955641
SIC: 2834 Pharmaceutical Preparations